SELECT LANGUAGE BELOW

New study connects cold sores and related viruses to Alzheimer’s disease risk

Study Links Cold Sores to Alzheimer’s Disease A recent study in BMJ Open suggests that cold sores might be implicated in the development of Alzheimer’s disease. Researchers analyzed data from 344,628 pairs of individuals, matched by age, gender, region, and healthcare visits, where one had Alzheimer’s and the other did not. In this study, 1,507 […]

Biden is urged to disclose complete disease history.

Biden’s Diagnosis and Calls for Transparency The Wall Street Journal has urged former President Biden, now 82, to be open about his health history following his announcement on Sunday that he has stage 4 prostate cancer. This disclosure has prompted several global leaders, including President Trump, to express their support for Biden and extend hopes […]

Global Health Organization Approves Pandemic Agreement, Increasing Its Authority over Global Disease Handling

Pandemic Agreement Adopted by WHO Members The World Health Parliament, a group aligned with the World Health Organization (WHO), officially approved a pandemic agreement on Tuesday. This international legal document encourages signatory countries to share medical technology, enhance vaccination efforts, and promote equity in healthcare. This agreement has sparked significant debate—originally regarded as a binding […]

Blood test that aids in diagnosing Alzheimer’s disease gets approval from FDA

Blood Tests for Alzheimer’s Diagnosis Approved In a significant move, U.S. health officials approved the first blood test aimed at diagnosing Alzheimer’s disease, with the hope of identifying potential patients. This test can assist doctors in differentiating whether a patient’s memory issues stem from Alzheimer’s or other medical conditions that affect cognitive function. The FDA […]

FDA approves first blood test for accurately predicting Alzheimer’s disease

On Friday, the Food and Drug Administration (FDA) revealed a new test designed to diagnose Alzheimer’s disease in adults. This is the first of its kind that uses blood samples to determine the presence of the illness. The test is known as the “Lumipulse g ptau217/ß-amyloid 1-42 plasma ratio” and was developed by Fujirebio Diagnostics, […]